Virologic failure in first-line human immunodeficiency virus therapy with a CCR5 entry inhibitor, aplaviroc, plus a fixed-dose combination of lamivudine-zidovudine: nucleoside reverse transcriptase inhibitor resistance regardless of envelope tropism (Q38969711)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Virologic failure in first-line human immunodeficiency virus therapy with a CCR5 entry inhibitor, aplaviroc, plus a fixed-dose combination of lamivudine-zidovudine: nucleoside reverse transcriptase inhibitor resistance regardless of envelope tropism |
scientific article |
Statements
1 reference
Virologic failure in first-line human immunodeficiency virus therapy with a CCR5 entry inhibitor, aplaviroc, plus a fixed-dose combination of lamivudine-zidovudine: nucleoside reverse transcriptase inhibitor resistance regardless of envelope tropism (English)
1 reference
James F Demarest
1 reference
Heather Amrine-Madsen
1 reference
David M Irlbeck
1 reference
Kathryn M Kitrinos
1 reference
CCR102881 Clinical Study Team
1 reference
15 December 2008
1 reference
1 reference
53
1 reference
1116-1123
1 reference
Identifiers
1 reference
1 reference
1 reference